Trial intelligence / Profile preview

Topical retapamulin versus oral cephalexin for secondarily infected dermatoses

2004-000784-97Phase 3Completed

Sponsor
GSK
Start
Dec 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Dermatopathy comparing Topical retapamulin arm with Oral cephalexin arm (2 arms). Primary endpoint: Clinical response at follow-up. Started Dec 2004; status: completed.

02

Drugs

retapamulincefalexin
03

Conditions

Dermatopathy

Beyond the preview

Go deeper on 2004-000784-97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-000784-97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call